Bleeding complications in patients on anticoagulants who would have been disqualified for clinical trials.
Levi
Marcel
M
Department of Internal Medicine, Academic Medical Centre F-4, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. m.m.levi@amc.uva.nl
Hovingh
Kees
K
D000925:Anticoagulants / Q000009:adverse effects*; D001777:Blood Coagulation / Q000187:drug effects; D002986:Clinical Trials as Topic / Q000379:methods*; D016903:Drug Monitoring; D019317:Evidence-Based Medicine; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D014812:Vitamin K